Evidence Review
Cognitive Function
The most thorough human trial on gotu kola and cognition (Wattanathorn et al., 2008; PMID 18191355) enrolled healthy elderly volunteers in a randomized, placebo-controlled design. Participants received 250 mg, 500 mg, or 750 mg of a standardized extract for two months. The 750 mg group showed significant improvements in working memory and a measurable change in the N100 event-related potential — a brain wave marker associated with attention and cognitive processing speed. This dose-dependent response is reassuring from a mechanistic standpoint.
A 2017 systematic review and meta-analysis by Puttarak et al. (PMID 28878245) analyzed 11 randomized controlled trials of Centella asiatica for cognitive and mood outcomes. The pooled analysis found significant improvements in mood outcomes including alertness, calmness, and reduced anger scores. Cognitive domain results were more mixed — some trials showed memory benefits while others did not — suggesting that study population, dose, and extract standardization matter considerably. The reviewers rated the overall evidence as moderate quality with potential for publication bias.
Anxiety
Bradwejn et al. (2000; PMID 11106141) conducted a randomized, double-blind, placebo-controlled crossover trial in 40 healthy adult volunteers. A single oral dose of 12 g of dried gotu kola (equivalent to ~500 mg of 24:1 extract) significantly attenuated the peak acoustic startle response at 30 and 60 minutes post-dose compared to placebo (p<0.05). The acoustic startle response is a validated biomarker of anxiety with good reproducibility. The study found no effect on baseline anxiety ratings, suggesting gotu kola dampens reactivity rather than inducing sedation — a clinically meaningful distinction.
Wound Healing and Collagen
Maquart et al. (1990; PMID 2354631) established the mechanistic foundation: asiaticoside isolated from gotu kola dose-dependently stimulated type I and III collagen synthesis in human fibroblast cultures without cytotoxicity. This in vitro work has been replicated in animal wound models where topical and oral asiaticoside application accelerated wound closure and increased breaking strength of healed tissue.
Clinically, the strongest evidence is in chronic venous insufficiency. A 2013 systematic review by Chong and Aziz (PMID 23533507) searched 13 databases and identified trials with adequate controls. Across multiple trials, Centella asiatica extract (TTFCA — total triterpenic fraction) significantly improved microcirculatory parameters: transcutaneous oxygen and carbon dioxide levels, ankle swelling, and venoarteriolar response. The consistent direction of effect across independent trials supports the mechanistic plausibility of vascular wall collagen strengthening.
Neuroprotection
Wong et al. (2021; PMID 34267660) reviewed the emerging evidence for Centella asiatica in neurodegenerative disease. The review catalogues multiple mechanisms: mitochondrial protection, reduction of amyloid-beta aggregation in Alzheimer's models, dopaminergic neuron protection in Parkinson's models, and anti-neuroinflammatory effects via suppression of NF-kB signaling. Most of this evidence comes from cell culture and animal models. Human trials specifically targeting neurodegeneration are limited, but the mechanistic breadth is notable and justifies ongoing clinical research.
Confidence Assessment
- Anxiety (acute): Moderate — supported by a well-designed RCT with objective biomarker; sample size small (n=40)
- Mood and alertness: Moderate — consistent across multiple trials per meta-analysis
- Cognitive enhancement (elderly): Low-to-moderate — promising but inconsistent across trials; needs larger replication
- Wound healing (topical/venous): Moderate-to-high — mechanistically solid, supported by multiple independent clinical trials
- Neuroprotection: Low (human evidence) — strong mechanistic basis but clinical trials in neurodegeneration are lacking
Gotu kola is one of the more multifaceted herbal medicines, with genuine peer-reviewed support across several distinct clinical areas. The anxiety and wound healing evidence is strong enough to inform practical use; the cognitive evidence is promising but not yet definitive.